Patent · US Active

Piperidine urea derivatives

US9770446B2 · kind B2 · utility

5Cited by

1References

4Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Hans-Peter Buchstaller · Griesheim, DE
Dieter Dorsch · Ober-Ramstadt, DE

Key dates

Filing date	Jul 9, 2014
Grant date	Sep 26, 2017
Priority date	—
Expiry date	Jul 9, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula Iin which R1-R3 have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.